SRC-1 and twist1 expression positively correlates with a poor prognosis in human breast cancer

International Journal of Biological Sciences

Volumn 10, Issue 4, 2014, Pages 396-403

  Xu, Yan ^a   Hu, Baoquan ^a   Qin, Li ^b   Zhao, Lianhua ^c   Wang, Qiang ^a   Wang, Qingliang ^a   Xu, Yixiang ^b   Jiang, Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Correlation; Prognosis; SRC 1; Twist1

Indexed keywords

NCOA1 PROTEIN, HUMAN; NUCLEAR PROTEIN; STEROID RECEPTOR COACTIVATOR 1; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN, HUMAN;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; NUCLEAR PROTEINS; NUCLEAR RECEPTOR COACTIVATOR 1; PROGNOSIS; SURVIVAL ANALYSIS; TWIST TRANSCRIPTION FACTOR;

EID: 84897068944     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.8193     Document Type: Article

References (34)

1. Xu J, Wu RC, O'Malley BW. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer. 2009; 9: 615-30. doi:10.1038/nrc2695.
2. Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai MJ, O'Malley BW. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science. 1998; 279: 1922-5.
3. Wang S, Yuan Y, Liao L, Kuang SQ, Tien JC, O'Malley BW, et al. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation. Proc Natl Acad Sci U S A. 2009; 106: 151-6. doi:10.1073/pnas.0808703105.
4. Qin L, Liu Z, Chen H, Xu J. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis. Cancer Res. 2009; 69: 3819-27. doi:10.1158/0008-5472.CAN-08-4389.
5. Qin L, Chen X, Wu Y, Feng Z, He T, Wang L, et al. Steroid receptor coactivator-1 upregulates integrin alpha(5) expression to promote breast cancer cell adhesion and migration. Cancer Res. 2011; 71: 1742-51. doi:10.1158/0008-5472.CAN-10-3453.
6. Fleming FJ, Hill AD, McDermott EW, O'Higgins NJ, Young LS. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer. J Clin Endocrinol Metab. 2004; 89: 375-83.
7. Han JS, Crowe DL. Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands. BMC Cancer. 2010; 10: 629. doi:10.1186/1471-2407-10-629.
8. Fleming FJ, Myers E, Kelly G, Crotty TB, McDermott EW, O'Higgins NJ, et al. Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1. J Clin Pathol. 2004; 57: 1069-74. doi:10.1136/jcp.2004.016733.
9. Myers E, Fleming FJ, Crotty TB, Kelly G, McDermott EW, O'Higgins N J, et al. Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer. Br J Cancer. 2004; 91: 1687-93. doi: 10.1038/sj.bjc.6602156.
10. Redmond AM, Bane FT, Stafford AT, McIlroy M, Dillon MF, Crotty TB, et al. Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence. Clin Cancer Res. 2009; 15: 2098-106. doi:10.1158/1078-0432.CCR-08-1649.
11. O'Rourke MP, Tam PP. Twist functions in mouse development. Int J Dev Biol. 2002; 46: 401-13.
12. Xu Y, Liao L, Zhou N, Theissen SM, Liao XH, Nguyen H, et al. Inducible knockout of twist1 in young and adult mice prolongs hair growth cycle and has mild effects on general health, supporting twist1 as a preferential cancer target. Am J Pathol. 2013; 183: 1281-92. doi:10.1016/j.ajpath.2013.06.021.
13. Qin Q, Xu Y, He T, Qin C, Xu J. Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res. 2012; 22: 90-106. doi:10.1038/cr.2011.144.
14. Yang J, Mani SA, Weinberg RA. Exploring a new twist on tumor metastasis. Cancer Res. 2006; 66: 4549-52. doi:10.1158/0008-5472.CAN-05-3850.
15. Riaz M, Sieuwerts AM, Look MP, Timmermans MA, Smid M, Foekens JA, et al. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes. Breast Cancer Res. 2012; 14: R123. doi: 10.1186/bcr3317.
16. Soini Y, Tuhkanen H, Sironen R, Virtanen I, Kataja V, Auvinen P, et al. Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer. 2011; 11: 73. doi:10.1186/1471-2407-11-73.
17. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999; 17: 1474-81.
18. Walsh CA, Qin L, Tien JC, Young LS, Xu J. The function of steroid receptor coactivator-1 in normal tissues and cancer. Int J Biol Sci. 2012; 8: 470-85. doi:10.7150/ijbs.4125.
19. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004; 117: 927-39. doi:10.1016/j.cell.2004.06.006.
20. Fu J, Qin L, He T, Qin J, Hong J, Wong J, et al. The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res. 2011; 21: 275-89. doi:10.1038/cr.2010.118.
21. McIlroy M, McCartan D, Early S, Gaora PÓ, Pennington S, Hill AD, et al. Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer. Cancer research. 2010; 70: 1585-94.
22. van Nes JG, de Kruijf EM, Putter H, Faratian D, Munro A, Campbell F, et al. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients. Breast cancer research and treatment. 2012; 133: 49-59.
23. Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol. 2005; 12: 488-96. doi:10.1245/ASO.2005.04.010.
24. Tan M, Yu D. Molecular mechanisms of erbB2-mediated breast cancer chemoresistance. Adv Exp Med Biol. 2007; 608: 119-29.
25. Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Buggy Y, et al. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer. Clin Cancer Res. 2005; 11: 2111-22. doi: 10.1158/1078-0432.CCR-04-1192.
26. McGuire WL, Clark GM. Role of progesterone receptors in breast cancer. CA Cancer J Clin. 1986; 36: 302-9.
27. Wei B, Wang J, Bourne P, Yang Q, Hicks D, Bu H, et al. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas. Hum Pathol. 2008; 39: 1809-15. doi:10.1016/j.humpath.2008.05.010.
28. Osborne CK, Schiff R, Arpino G, Lee AS, Hilsenbeck VG. Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy. Breast. 2005; 14: 458-65. doi: 10.1016/j.breast.2005.08.024.
29. Tang P, Wang J, Hicks DG, Wang X, Schiffhauer L, McMahon L, et al. A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer. Cancer Invest. 2010; 28: 978-82. doi:10.3109/07357907.2010.496754.
30. Hong J, Zhou J, Fu J, He T, Qin J, Wang L, et al. Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res. 2011; 71: 3980-90. doi:10.1158/0008-5472.CAN-10-2914.
31. Vesuna F, Lisok A, Kimble B, Domek J, Kato Y, van der Groep P, et al. Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-alpha. Oncogene. 2012; 31: 3223-34. doi:10.1038/onc.2011.483.
32. Fu J, Zhang L, He T, Xiao X, Liu X, Wang L, et al. TWIST represses estrogen receptor-alpha expression by recruiting the NuRD protein complex in breast cancer cells. Int J Biol Sci. 2012; 8: 522-32. doi:10.7150/ijbs.4164.
33. Markiewicz A, Ahrends T, Wełnicka-Jaśkiewicz M, Seroczyńska B, Skokowski J, Jaśkiewicz J, et al. Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer. Journal of translational medicine. 2012; 10: 1-11.
34. Ou DL, Chien HF, Chen CL, Lin TC, Lin LI. Role of Twist in head and neck carcinoma with lymph node metastasis. Anticancer Res. 2008; 28: 1355-9.